Voluven??

Quote






Look Nimrod

You don't ask these types of questions in a 3 party chat room expecting to get the right answer from a 200 degrees of seperation sales person. Use your brain to email or call the Voluven marketing manager to get the correct answer. You might not always like to answer you get but they understand all the risks involved when making the decision.
 






Anonymous said:
Look Nimrod

You don't ask these types of questions in a 3 party chat room expecting to get the right answer from a 200 degrees of seperation sales person. Use your brain to email or call the Voluven marketing manager to get the correct answer. You might not always like to answer you get but they understand all the risks involved when making the decision.
Click to expand...

EXACTLY!! In this business it's CYA. Too many people looking to make the fast buck suing drug companies and too many employees looking to get rich by whistle-blowing.

Better safe than sorry. We're in good hands with our product management.
 












Can't prove claims re: safety or efficacy.
Insufficient data in cardiac patients.
Affects coagulation( even though we say it doesn't) like any other colloid.
Renal clearance better but not great.....kidney damage?
Studies to date show equivalence but not superiority....justify a $50.00/bag price?

You connect the dots.
 












Why not go to straight commission vs. quota on a dying product with questionable safety?

I know.....save money by not paying bonus.

Management makes the blunders; we pay the price.
 












CHEST.....Voluven is poison to the kidneys. Surprise, surprise. Now we wait for the "spin" the usual BS based on nothing. Dump this dog and move on.....oops, we have nothing else to sell except generic Precedex, and the future blockbuster Dyloject. Whoppee!
 






Top Bottom
Back
Quote